AONC American Oncology Network Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AONC

Price (delayed)

$3.93

Market cap

$140.37M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.36

Enterprise value

$238.96M

Highlights
The equity has surged by 53% since the previous quarter
The revenue has grown by 11% YoY
The gross margin has declined by 22% year-on-year
American Oncology Network's gross profit has decreased by 13% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://dtocorp.com
Peers: TOI

Key stats

What are the main financial stats of AONC
Market
Shares outstanding
35.72M
Market cap
$140.37M
Enterprise value
$238.96M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.02
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.19
Earnings
Revenue
$1.28B
EBIT
-$56.67M
EBITDA
-$39.93M
Free cash flow
-$29.7M
Per share
EPS
-$1.36
Free cash flow per share
-$4.44
Book value per share
-$4.67
Revenue per share
$191.34
TBVPS
$55.83
Balance sheet
Total assets
$374.45M
Total liabilities
$303.74M
Debt
$127.14M
Equity
-$161.73M
Working capital
$108.76M
Liquidity
Debt to equity
-0.79
Current ratio
1.64
Quick ratio
1.35
Net debt/EBITDA
-2.47
Margins
EBITDA margin
-3.1%
Gross margin
6.5%
Net margin
-5%
Operating margin
-3.8%
Efficiency
Return on assets
-1.6%
Return on equity
N/A
Return on invested capital
-19.3%
Return on capital employed
-27.6%
Return on sales
-4.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AONC stock price

How has the American Oncology Network stock price performed over time
Intraday
1.03%
1 week
-14.38%
1 month
-34.17%
1 year
-61.55%
YTD
-33.39%
QTD
-28.42%

Financial performance

How have American Oncology Network's revenue and profit performed over time
Revenue
$1.28B
Gross profit
$82.8M
Operating income
-$49.15M
Net income
-$63.47M
Gross margin
6.5%
Net margin
-5%
The gross margin has declined by 22% year-on-year
American Oncology Network's gross profit has decreased by 13% YoY
The revenue has grown by 11% YoY

Growth

What is American Oncology Network's growth rate over time

Valuation

What is American Oncology Network stock price valuation
P/E
N/A
P/B
N/A
P/S
0.02
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.19
The equity has surged by 53% since the previous quarter
The revenue has grown by 11% YoY

Efficiency

How efficient is American Oncology Network business performance

Dividends

What is AONC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AONC.

Financial health

How did American Oncology Network financials performed over time
AONC's total assets is 23% higher than its total liabilities
AONC's total assets is up by 15% YoY but it is down by 5% QoQ
The total liabilities is up by 15% YoY
AONC's debt is 179% greater than its equity
The company's debt to equity has shrunk by 139% YoY and by 108% QoQ
The equity has surged by 53% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.